TFS Capital’s Apyx Medical APYX Stock Holding History

TFS Capital’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-17,496	Closed	-$91K	–	724
2016 Q3	$91K	Buy	+17,496	New	+$56.7K	0.02%	662

Other funds holding APYX

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EAM Investors Solana Beach, California $1.12B AUM 390.6% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

TFS Capital's APYX Position: Q4 2016 in Review

TFS Capital sold out of Apyx Medical (APYX) in Q4 2016, closing a stake of 17,496 shares — an estimated $91K sold.

TFS Capital first reported a position in APYX in Q3 2016 and held it in 1 quarter. The position peaked at $91K in Q3 2016. 39 funds tracked by Wall St. Rank hold APYX as of Q4 2016.

TFS Capital reported no remaining Apyx Medical position as of Q4 2016 after selling out during the quarter.
TFS Capital sold 17,496 Apyx Medical shares in Q4 2016, an estimated $91K.
TFS Capital first reported a position in Apyx Medical in Q3 2016 and held it in 1 quarter.
TFS Capital's Apyx Medical position peaked at $91K in Q3 2016.
39 funds tracked by Wall St. Rank held Apyx Medical as of Q4 2016.

Based on TFS Capital's 13F filing for Q4 2016, filed 20 Jan 2017.